Amphastar Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$763.98 | $636.99 | 14.86% | 9 | $687.89B |
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr910.00 | kr696.07 | 5.77% | 14 | kr4.05T |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.55k | Rp1.52k | 2.57% | 25 | Rp3.71T |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$17.09 | $11.59 | -0.53% | 9 | $19.36B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr635.50 | kr357.00 | 28.25% | 2 | kr40.95B |
| HALO | Halozyme Therapeutics | Outperform |
11
|
$43.82 | $47.50 | 9.54% | 3 | $5.58B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£20.02 | £28.11 | 45.90% | 9 | £4.42B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$71.47 | $71.50 | 4.24% | 3 | $3.55B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.12 | $9.50 | 33.43% | 5 | $2.55B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.85 | $6.13 | 16.79% | 1 | $2.09B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$28.97 | $41.00 | 41.53% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$66.03 | $69.75 | 21.16% | 1 | $1.38B |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.90 | $4.60 | 163.16% | 1 | $260.93M |
| EBS | Emergent BioSolutions | Outperform |
16
|
$5.08 | $5.00 | -1.57% | 0 | $229.00M |
| ASRT | Assertio Holdings | Buy |
8
|
$1.01 | $3.50 | 197.03% | 2 | $100.36M |
| OPNT | Opiant Pharmaceuticals | - |
10
|
$20.77 | $21.00 | -100.00% | 0 | $63.99M |
| EGRX | Eagle Pharmaceuticals | - |
14
|
$4.67 | $17.00 | -100.00% | 0 | $60.52M |
| LCI | Lannett Company | - |
10
|
$0.03 | $4.00 | -100.00% | 1 | $21.85M |
| ENDP.Q | Endo International | - |
14
|
$0.00 | $1.33 | 0.00% | 0 | $1.18M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $0.53M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | $1.50 | -100.00% | 0 | $0.35M |